The AQP2 gene helps the kidneys return water to the body, which lets you make more concentrated urine and stay hydrated. This gene plays an important role in how your body balances fluid from hour to hour. If the AQP2 gene does not work properly, water stays in the urine, so a person may pass large amounts of very dilute urine, feel very thirsty, and become dehydrated more easily. Harmful variants in the AQP2 gene are linked to nephrogenic diabetes insipidus.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or direct processes in the body. Some genes contain the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes take place, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. You can find more detailed information about this topic in the LearnHub.
Overview
AQP2Gene function
What if the gene works
The AQP2 gene helps kidney cells move water back into the body. This supports fluid balance and lets urine become more concentrated when your body needs to save water.
Risk
What if the gene does not work
Variants in the AQP2 gene can cause nephrogenic diabetes insipidus, with poor urine concentration, excessive urination, and strong thirst. Milder or more severe variants can influence how early symptoms appear and how pronounced they are, sometimes raising dehydration risk.
Treatment
What does that mean for your treatment
A pathogenic variant in the AQP2 gene usually points to treatment approaches used for congenital nephrogenic diabetes insipidus. Desmopressin often helps little or not at all, so care usually centers on free water access, a low salt diet, and medicines such as thiazide diuretics, often with amiloride, and sometimes indomethacin. Rare dominant variants may show partial desmopressin response.
Conditions associated with AQP2
Gene function
What if the gene works
Day to day fluid balance depends partly on the AQP2 gene. In the kidneys, it helps control how much water is returned to the body instead of leaving in urine. This steady fine tuning supports normal hydration and helps the body make urine that is more or less concentrated as needed.
The AQP2 gene gives kidney cells instructions to make a protein channel that lets water pass through the cell surface. This controlled water movement is a basic part of how the kidneys handle fluid.
In the collecting ducts of the kidneys, the AQP2 gene helps cells respond to vasopressin, a hormone that tells the body to conserve water. The AQP2 protein moves to the right place on the cell surface when extra water needs to be reclaimed.
By letting more or less water move back into the body, the AQP2 gene supports water balance and urine concentration. This is a key part of what the AQP2 gene does in the kidneys during everyday changes in drinking, sweating, and sleep.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence of a gene. These changes are common and help explain normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AQP2 gene can reduce how well the kidney water channel is made, folded, or moved to the cell surface, so cells respond less effectively to vasopressin, the hormone that helps the body hold on to water. Some AQP2 gene variants leave partial channel activity, while more severe variants can block water flow or trap the protein inside the cell. A few variants also interfere with normal copies of the channel. This range helps explain why AQP2-related nephrogenic diabetes insipidus may appear earlier or be more pronounced in some people.
How variants are linked to conditions
Pathogenic variants in the AQP2 gene cause nephrogenic diabetes insipidus, an inherited condition in which the kidneys cannot conserve water normally. People with this diagnosis often pass large amounts of urine and feel very thirsty from infancy or childhood. Most confirmed AQP2-related cases are inherited in an autosomal recessive pattern, while a smaller number follow an autosomal dominant pattern.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For AQP2, risk is mainly set by whether you inherited a disease-causing variant, so family history is the main factor that changes the chance of having this condition. There is not enough evidence to say lifestyle lowers that inherited risk, although heat, illness, and not drinking enough fluids can make symptoms worse in people already living with it.
Inheritance of AQP2 variants
The inheritance pattern for AQP2-related nephrogenic diabetes insipidus can differ depending on the specific variant. Most disease-causing changes in the AQP2 gene are inherited in an autosomal recessive way, which means a child usually inherits one variant from each parent. Some variants in the AQP2 gene are inherited in an autosomal dominant way, so one changed copy can be enough to cause the condition. In practical terms, how AQP2 variants are inherited does not depend on whether the child is male or female, because the gene is on chromosome 12.
What does my AQP2 result mean for my family?
AQP2 changes are linked to a rare condition that affects the kidneys’ ability to save water, causing very large amounts of urine and strong thirst. For family members, the meaning depends on the specific AQP2 result, because some AQP2-related cases run in families in a dominant way, while others are recessive and may show up when both parents are healthy carriers. Close relatives may also carry the same change or be affected, so the result can matter for siblings, parents, and children.
Genetic information
Genetic testing
How you find out about variants
AQP2 genetic testing usually uses a blood or saliva sample to read the AQP2 gene and look for variants linked to inherited nephrogenic diabetes insipidus. Labs compare your DNA with a reference sequence and may report a variant as benign, uncertain, or disease causing. Results can show whether an AQP2 variant explains symptoms or is present in relatives.
When should I consider getting a genetic test?
Consider genetic testing for AQP2 if someone has ongoing extreme thirst and passes very large amounts of pale urine, especially from infancy or early childhood, or if this runs in the family. Changes in AQP2 can cause an inherited condition called nephrogenic diabetes insipidus, which makes the kidneys unable to conserve water.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it into tissues, or responds to it at its target, so the same treatment may work better for one person than another. This kind of variation is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It focuses on links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes affect both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the AQP2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine response, so general questions about kidney symptoms, hydration, or medication side effects are best discussed with your doctor.
History
In the early 1990s, researchers identified the AQP2 gene as part of the newly recognized aquaporin family, a milestone in kidney genetics. Soon after, scientists showed that changes in this gene were linked to inherited nephrogenic diabetes insipidus, helping explain a long puzzling cause of severe thirst and passing large amounts of urine. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became easier to classify in affected families. Building on this early work, scientists uncovered more about the AQP2 gene through laboratory studies and family-based genetic testing. These findings helped move care from symptom-based descriptions toward clearer genetic diagnosis.